Province reports 1st death related to VITT blood-clotting syndrome

Marco Green
May 26, 2021

"They fully intend to contact all their customers and individuals that received the AstraZeneca dose so give them the opportunity to do that", she said. "We have not heard of people dying because they did not get the second dose", he said.

He said "we wouldn't mind you waiting for 12 weeks", if possible, but since they have vaccines that need to be utilized before expiry, those who received their first shots during the initial AstraZeneca pharmacy pilot project in the Toronto, Kingston and Windsor areas are being prioritized for their second dose slightly earlier.

To date, Ontario has administered approximately 850,000 doses of this particular vaccine.

"We are struggling economically ... that's why we have problems funding the deployment itself". The female was vaccinated with AstraZeneca two weeks before the incident and is in good condition, the health ministry added.

"We don't want to run the risk of [the vaccine] expiring in our hands".

She was told by hotline staff that they couldn't book second doses.

While 72 000 will be returned to the Covax facility, the country will keep 52 000 of the doses that it hopes to use before the expiration date.

The AstraZeneca vaccine has been administered to over 740,000 Greek citizens so far.

Once that batch is finished, it will request additional doses from Covax, the ministry said.

Covax told the government they were "very happy with this arrangement", according to Achiek.

As in other parts of Africa, a fear of side effects and rumours the vaccine causes impotence or is otherwise unsafe have spurred wariness about vaccines among the population.

The vaccines are set to expire in July.

In London and surrounding Middlesex County, 11 new COVID-19 cases were recorded in the daily update made public Tuesday.

The third round opt-in registration for the AstraZeneca Covid-19 vaccine closed today after all allocated slots were snapped up within an hour after the registration drive went live despite persisting technical glitches.

Dr. Barbara Yaffe, Ontario's associate chief medical officer of health, said that while the death is still being investigated, the man did have the blood-clotting disorder known as Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT).

The decision, officials said, was a result of soaring infections and inadequate vaccine production by the two main private manufacturers, the Serum Institute of India (SII), which makes AstraZeneca's vaccine, and Bharat Biotech, that makes Covaxin.

"We're seeing now with some new data from the United Kingdom that people who get two doses, as [time] goes on, their immunity keeps getting stronger and stronger, approaching some of that equal to the mRNA vaccines", he said.

Other reports by Click Lancashire

Discuss This Article